LncRNA MEG3 Ameliorates NiO Nanoparticles-Induced Pulmonary Inflammatory Damage via Suppressing the p38 Mitogen Activated Protein Kinases Pathway

Wistar rats were treated with nickel oxide nanoparticles (NiO NPs) suspensions by intratracheal instillation twice-weekly for nine weeks. A549 cells were treated with NiO NPs suspensions for 24 hour.